Related Experiment Videos
Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP)
Abstract:
Muramyl dipeptide (MDP) is a low molecular (less than 500 daltons) synthetic analogue of a streptococcal peptidoglycan subunit. It was demonstrated to be the minimal structure essential for eliciting the adjuvant effect ascribed to Freund's complete adjuvant (FCA). MDP was likewise shown to represent the minimal requirement for peptidoglycan-induced changes in temperature and it was at first concluded that there was an almost perfect correlation between pyrogenicity and adjuvant activity. However, other experiments showed that certain MDP derivatives were as adjuvant active without eliciting a febrile response in the rabbit. Moreover an anti-inflammatory substance such as indomethacin completely inhibits the pyrogenic effect of MDP but does not affect or even enhance various of its immunostimulant properties. Inhibition of MDP-induced fever is not associated with modification of leucopenia or production of circulating endogenous pyrogens observed after MDP injection. Indomethacin incubated with peritoneal macrophage cultures at a dose which blocks prostaglandin synthesis, does not decrease the production by MDP of endogenous pyrogens.
Insights
Muramyl dipeptide (MDP) is a key immune-stimulating molecule. Research shows its fever-inducing effects can be blocked without losing its beneficial immunostimulant properties.
Area of Science:
- Immunology
- Pharmacology
Background:
- Muramyl dipeptide (MDP) is a synthetic analogue of streptococcal peptidoglycan.
- MDP is the minimal structure responsible for the adjuvant effect of Freund's complete adjuvant (FCA).
- Initially, MDP's pyrogenicity and adjuvant activity were considered closely correlated.
Purpose of the Study:
- To investigate the relationship between MDP's pyrogenic and immunostimulant effects.
- To determine if fever induction is essential for MDP's adjuvant activity.
Main Methods:
- Administering MDP and its derivatives to rabbits.
- Using indomethacin, an anti-inflammatory drug, to inhibit MDP-induced fever.
- Analyzing effects on leucopenia and endogenous pyrogen production.
- Culturing peritoneal macrophages with MDP and indomethacin.
Main Results:
- Certain MDP derivatives retain adjuvant activity without causing fever.
- Indomethacin inhibits MDP-induced fever but not its immunostimulant properties.
- Inhibition of fever did not alter leucopenia or endogenous pyrogen production.
Conclusions:
- MDP's pyrogenic and immunostimulant effects are dissociable.
- Fever induction is not required for MDP's immunostimulant or adjuvant activities.
- Prostaglandin synthesis inhibition does not affect MDP-induced pyrogen production by macrophages.